Filing Details

Accession Number:
0001209191-15-028969
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-24 18:02:06
Reporting Period:
2015-03-20
Filing Date:
2015-03-24
Accepted Time:
2015-03-24 18:02:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1406338 Amit Sachdev C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Evp, Policy, Access & Value No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-03-20 1,468 $48.74 91,452 No 4 M Direct
Common Stock Acquisiton 2015-03-20 10,532 $45.11 101,984 No 4 M Direct
Common Stock Disposition 2015-03-20 12,000 $135.08 89,984 No 4 S Direct
Common Stock Disposition 2015-03-23 300 $122.78 89,684 No 4 S Direct
Common Stock Disposition 2015-03-23 1,783 $125.07 87,901 No 4 S Direct
Common Stock Disposition 2015-03-23 2,200 $125.93 85,701 No 4 S Direct
Common Stock Disposition 2015-03-23 600 $127.16 85,101 No 4 S Direct
Common Stock Disposition 2015-03-23 200 $127.90 84,901 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2015-03-20 1,468 $0.00 1,468 $48.74
Common Stock Stock Option (right to buy) Disposition 2015-03-20 10,532 $0.00 10,532 $45.11
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
29,032 2022-07-24 No 4 M Direct
28,593 2023-02-04 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 882 Indirect 401(k)
Footnotes
  1. Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.
  2. Open market sales reported on this line occurred at a weighted average price of $122.78 (range $122.46 to $123.24).
  3. Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  4. Open market sales reported on this line occurred at a weighted average price of $125.07 (range $124.56 to $125.51).
  5. Open market sales reported on this line occurred at a weighted average price of $125.93 (range $125.61 to $126.50).
  6. Open market sales reported on this line occurred at a weighted average price of $127.16 (range $126.74 to $127.72).
  7. Open market sales reported on this line occurred at a weighted average price of $127.90 (range $127.87 to $127.92).
  8. The option vests in 16 quarterly installments from 07/25/2012.
  9. The option vests in 16 quarterly installments from 02/05/2013.